Genetic testing for breast cancer susceptibility: Frequency of BRCA1 and BRCA2 mutations

Genetic Testing

Volumn 1, Issue 2, 1997, Pages 85-90

  Ganguly, Arupa ^a,b   Leahy, Kevin ^a   Marshall, Andrew M ^a   Dhulipala, Rohini ^a   Godmilow, Lynn ^a   Ganguly, Tapan ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; DNA; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

ADULT; ARTICLE; BREAST TUMOR; FEMALE; GENE FREQUENCY; GENETIC SCREENING; GENETICS; HUMAN; JEW; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; ONSET AGE; PREDICTION AND FORECASTING; TUMOR SUPPRESSOR GENE;

ADULT; AGE OF ONSET; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENES, BRCA1; GENES, TUMOR SUPPRESSOR; GENETIC SCREENING; HUMANS; JEWS; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; TRANSCRIPTION FACTORS;

EID: 0031292265     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.1997.1.85     Document Type: Article

References (21)

1. BERMAN, D.E., WAGNER-COSTALAS, J., SCHULTZ, D.C., LYNCH, H.T., DALY, M., and GODWIN, A.K. (1996). Two distinct origins of a common BRCA1 mutation in breast-ovarian families: A genetic study of 15 185delAG-mutation kindreds. Am. J. Hum. Genet. 58, 1166-1176.
2. CHRISTIANO, A.M., MCGRATH, J.A., TAN, K.C., and UITTO, J. (1996a). Glycine substitutions in the triple helical region of type VII collagen result in a spectrum of dystrophic epidermolysis bullosa phenotypes and patterns of inheritance. Am. J. Am. Genet. 58, 671-681.
3. CHRISTIANO, A.M., ANTON-LAMPRECHT, I., AMANO, S., EBSCHNER, U., BURGESON, R., and UITTO, J. (1996b). Compound heterozygosity for COL7A1 mutations in twins with dystrophic epidermolyses bullosa: A recessive paternal deletion/insertion mutation and a dominant negative maternal glycine substitution result in a severe phenotype. Am. J. Hum. Genet. 58, 682-693.
4. COUCH, F.J., DESHANO, M.L., BLACKWOOD, M.A., CALZONE, K., STOPFER, J., CAMPEAU, L., GANGULY, A., REBBECK, T., and WEBER, B.L. (1997). BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N. Engl. J. Med. 15, 1409-1415.
5. COUCH, F.J. et al. (1996). BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nature Genet. 13, 123-125.
6. COUCH, F.J., WEBER, B.L., and the BREAST CANCER INFORMATION CORE (1996). Mutations and polymorphisms in the familial early-onset breast cancer gene. Hum. Mutat. 8, 8-18.
7. EASTON, D.F., BISHOP, D.T., FORD, D., CROCKFORD, G.P., and the BREAST CANCER LINKAGE CONSORTIUM. (1993). Genetic linkage analysis in familial breast and ovarian cancer - Results from 214 families. Am. J. Hum. Genet. 52, 678-701.
8. FRIEDMAN, L.S. et al. (1995). Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am. J. Hum. Genet. 57, 1284-1297.
9. GANGULY, A., ROCK, M.J., and PROCKOP, D.J. (1993). Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: Evidence for solvent-induced bends in DNA heteroduplexes. Proc. Natl. Acad. Sci. USA 90, 10325-10329.
10. GANGULY, A., CALZONE, C., COUCH, F.J., DESHANO, M., WEBER, B., and MARSHALL, A. (1995). Evaluation of conformation sensitive gel electrophoresis for rapid mutation analyses of BRCA1 breast and ovarian cancer gene. Paper presented at 45th Annual Meeting of American Society of Human Genetics. Am. J. Hum. Genet. 57, A46.
11. GANGULY, A., LEAHY, K.D., DHULIPALA, R., GODMILOW, L., and GANGULY, T. (1996). Hereditary breast and ovarian cancer syndrome: A significant fraction of familial cases is not caused by mutations in BRCA1 or BRCA2 genes. Paper presented at 46th Annual Meeting of American Society of Human Genetics. Am. J. Hum. Genet. 59, A35.
12. HALL, J.M., LEE, M.K., NEWMAN, B., MORROW, J.E., ANDERSON, L.A., HUEY, B., and KING, M.-C. (1990). Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250, 1684-1689.
13. KORKKO, J., PIHLAJAMAA, T., PROCKOP, D.J., and ALA KOKKO, L. (1996). Comparison of conformation sensitive gel electrophoresis with denaturing gel electrophoresis for detection of single base mutations in PCR products. Sixth International Conference on Matrix Biology, III-3.
14. MIKI, Y. et al. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71.
15. OFFIT, K. et al. (1996). Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. J. Clin. Onc. 14, 1730-1736.
16. REBBECK, T.R., COUCH, F.J., KANT, J., CALZONE, K., DESHANO, M., PENG, Y., CHEN, K., GARBER, J.E., and WEBER, B.L. (1996). Genetic heterogeneity in hereditary breast cancer: Role of BRCA1 and BRCA2. Am. J. Hum. Genet. 59, 547-553.
17. STREWING, J.P., ALBELIOVICH, D., PERETZ, T., AVISHAI, N., KABACK, M.M., COLLINS, F.S., and BRODY, L.C. (1996). The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat. Genet. 11, 198-200.
18. TAVITIGIAN, S.V. et al. (1996). The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat. Genet. 12, 333-337.
19. WILLIAMS, C.J., ROCK, M., CONSIDENE, E., MCCARRON, S., GOW, P., LADDA, R., MCLAIN, D., MICHELS, V., MURPHY, W., PROCKOP, D.J., and GANGULY, A. (1995). Rapid detection of mutations by conformation sensitive gel electrophoresis. Application to identification of a fourth family with the Arg → Cys substitution and three new mutations in the type II procollagen gene. Hum. Mol. Genet. 4, 309-312.
20. WOOSTER, R. et al. (1994). Localization of breast cancer susceptibility gene BRCA2 to chromosome 13q12-13, Science 265, 2088-2090.
21. WOOSTER, R. et al. (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789-792.